Calcipotriol Hydrate/Betamethasone Dipropionate

卡泊三醇水合物/倍他米松二丙酸酯

Report date: 2026/04/17 20:02:02

Base Information

Drug NameCalcipotriol Hydrate/Betamethasone Dipropionate
Drug Alias NameCalcipotriol/betamethasone dipropionate二丙酸酯倍他米松/卡泊三醇水合物Betamethasone Dipropionate/Calcipotriene HydrateDaivobet 50/500 OintmentDovobet +[16] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsVitamin D receptor antagonists
TargetsGlucocorticoid receptorVitamin D receptor
Therapy Area/IndicationsPlaque psoriasisPsoriasisSkin and Connective Tissue Diseases
Global Approved IndicationsPlaque psoriasisPsoriasis
Approved Indications in ChinaPlaque psoriasisPsoriasis
Original Approved Country/TerritoryMainland China
Original Approved Date2008/09/01
Country/TerritoryCzechiaBelgiumCanada +[23] 
CombinationsYes CalcipotriolBetamethasone Dipropionate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLeo Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesLeo Pharma IncLeo Laboratories LtdLeo Pharma A/S
Inactive CompaniesAbbott LaboratoriesLeo Pharma Consultancy(Shanghai)Company LtdTolmar Inc +[4] 
Active IndicationsPlaque psoriasisPsoriasis
Inactive IndicationsSkin and Connective Tissue Diseases

Other Information

ATC CodeD05AX52
Related LinksKEGG